跳至主要内容
临床试验/IRCT20120629010133N7
IRCT20120629010133N7已完成1 期

Intranasal versus intravenous administration of naloxone in pediatric opioid poisoned patients, A pilot randomized clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 12 years(—)
性别
All

入选标准

  • Age more than 1 and less than 12
  • Opioid poisoning
  • Respiratory depression
  • Miotic pupils
  • Unarousable as defined by Glasgow Coma Score (GCS) = 12/15

排除标准

  • Still conscious on ED arrival time
  • Patients that have received naloxone in any form in the previous 24 hours
  • Referral cases with unknown drug intervention
  • Patients who have been referred with IV access
  • Presentation with apnea
  • Nasal congestion
  • No parental deferred consent provided
  • GCS < 7/15
  • History of drug hypersensitivity relevant to naloxone
  • Co-ingestion of other drugs
  • Intubation before recruitment
  • major facial trauma
  • Negative urine screening test for opioids
  • A clinical condition (such as abnormal liver function; respiratory, renal or cardiac issues) which, in the opinion of the examining medical practitioner, makes participation in the study inappropriate.

研究者

相似试验